Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |